153 related articles for article (PubMed ID: 16644350)
1. Assessment of patent foramen ovale in carcinoid heart disease.
Mansencal N; Mitry E; Forissier JF; Martin F; Redheuil A; Lepère C; Farcot JC; Joseph T; Lacombe P; Rougier P; Dubourg O
Am Heart J; 2006 May; 151(5):1129.e1-6. PubMed ID: 16644350
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.
Mansencal N; Mitry E; Pillière R; Lepère C; Gérardin B; Petit J; Gandjbakhch I; Rougier P; Dubourg O
Am J Cardiol; 2008 Apr; 101(7):1035-8. PubMed ID: 18359327
[TBL] [Abstract][Full Text] [Related]
3. Patent foramen ovale in carcinoid heart disease.
Mansencal N; Touhami I; Mitry E; Rougier P; Dubourg O
Int J Cardiol; 2010 Jul; 142(2):e29-31. PubMed ID: 19157592
[TBL] [Abstract][Full Text] [Related]
4. Comparison of prognostic value of tissue Doppler imaging in carcinoid heart disease versus the value in patients with the carcinoid syndrome but without carcinoid heart disease.
Mansencal N; McKenna WJ; Mitry E; Beauchet A; Pellerin D; Rougier P; Dubourg O
Am J Cardiol; 2010 Feb; 105(4):527-31. PubMed ID: 20152249
[TBL] [Abstract][Full Text] [Related]
5. Age is not a predictor of patent foramen ovale with right-to-left shunt in patients with cerebral ischemic events.
Yahia AM; Shaukat A; Kirmani JF; Qureshi AI
Echocardiography; 2004 Aug; 21(6):517-22. PubMed ID: 15298687
[TBL] [Abstract][Full Text] [Related]
6. Echocardiographic follow-up of treated patients with carcinoid syndrome.
Mansencal N; Mitry E; Bachet JB; Rougier P; Dubourg O
Am J Cardiol; 2010 Jun; 105(11):1588-91. PubMed ID: 20494667
[TBL] [Abstract][Full Text] [Related]
7. Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century.
Bhattacharyya S; Toumpanakis C; Caplin ME; Davar J
Am J Cardiol; 2008 Feb; 101(3):378-81. PubMed ID: 18237604
[TBL] [Abstract][Full Text] [Related]
8. Profound hypoxaemia corrected by PFO closure device in carcinoid heart disease.
Mottram PM; McGaw DJ; Meredith IT; Peverill RE; Harper RW
Eur J Echocardiogr; 2008 Jan; 9(1):47-9. PubMed ID: 17018264
[TBL] [Abstract][Full Text] [Related]
9. Carcinoid heart disease with right to left shunt across a patent foramen ovale: a case report and review of literature.
Chowdhury MA; Taleb M; Kakroo MA; Tinkel J
Echocardiography; 2015 Jan; 32(1):165-9. PubMed ID: 24976489
[No Abstract] [Full Text] [Related]
10. Patent foramen ovale in carcinoid heart disease: The potential role for and risks of percutaneous closure prior to cardiothoracic surgery.
Douglas S; Oelofse T; Shah T; Rooney S; Arif S; Steeds RP
J Neuroendocrinol; 2023 Aug; 35(8):e13323. PubMed ID: 37580851
[TBL] [Abstract][Full Text] [Related]
11. Carcinoid heart disease with severe hypoxia due to interatrial shunt through patent foramen ovale.
Boglioli LR; Gardiner J; Gerstenblith G; Taff ML; Cameron DE
Tex Heart Inst J; 1997; 24(2):125-8. PubMed ID: 9205988
[TBL] [Abstract][Full Text] [Related]
12. Urgent transcatheter closure of patent foramen ovale followed by elective right-sided valve surgery for decompensated carcinoid heart disease.
Hayashi Y; McGaw DJ; Goldstein J
Heart Lung Circ; 2008 Jun; 17(3):259-61. PubMed ID: 17416551
[TBL] [Abstract][Full Text] [Related]
13. Platypnea-orthodeoxia syndrome in the elderly treated by percutaneous patent foramen ovale closure: a case series and literature review.
Blanche C; Noble S; Roffi M; Testuz A; Müller H; Meyer P; Bonvini JM; Bonvini RF
Eur J Intern Med; 2013 Dec; 24(8):813-7. PubMed ID: 24007641
[TBL] [Abstract][Full Text] [Related]
14. Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events.
Schuchlenz HW; Saurer G; Weihs W; Rehak P
J Am Soc Echocardiogr; 2004 Mar; 17(3):231-3. PubMed ID: 14981420
[TBL] [Abstract][Full Text] [Related]
15. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI.
Bhattacharyya S; Toumpanakis C; Burke M; Taylor AM; Caplin ME; Davar J
Circ Cardiovasc Imaging; 2010 Jan; 3(1):103-11. PubMed ID: 19920029
[TBL] [Abstract][Full Text] [Related]
16. Patent foramen ovale with atrial septal aneurysm may contribute to white matter lesions in stroke patients.
Ueno Y; Shimada Y; Tanaka R; Miyamoto N; Tanaka Y; Hattori N; Urabe T
Cerebrovasc Dis; 2010; 30(1):15-22. PubMed ID: 20424440
[TBL] [Abstract][Full Text] [Related]
17. Second harmonic transthoracic echocardiography: the new reference screening method for the detection of patent foramen ovale.
Daniëls C; Weytjens C; Cosyns B; Schoors D; De Sutter J; Paelinck B; Muyldermans L; Van Camp G
Eur J Echocardiogr; 2004 Dec; 5(6):449-52. PubMed ID: 15556821
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients.
Wahl A; Krumsdorf U; Meier B; Sievert H; Ostermayer S; Billinger K; Schwerzmann M; Becker U; Seiler C; Arnold M; Mattle HP; Windecker S
J Am Coll Cardiol; 2005 Feb; 45(3):377-80. PubMed ID: 15680715
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of left-sided carcinoid heart disease.
Connolly HM; Schaff HV; Mullany CJ; Rubin J; Abel MD; Pellikka PA
Circulation; 2001 Sep; 104(12 Suppl 1):I36-40. PubMed ID: 11568027
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical significance of a patent foramen ovale in patients with chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Kosar FM; Sahin I; Kilic T
Respir Med; 2006 May; 100(5):903-10. PubMed ID: 16214323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
